Testing effectiveness (Phase 2)Temporarily pausedNCT03097107
What this trial is testing
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Who this might be right for
Dyslipidemias
Zydus Therapeutics Inc. 124